Randomized Controlled Pilot Study of Combivir for Patients With Primary Biliary Cirrhosis.

Trial Profile

Randomized Controlled Pilot Study of Combivir for Patients With Primary Biliary Cirrhosis.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 02 Dec 2011

At a glance

  • Drugs Lamivudine/zidovudine (Primary)
  • Indications Primary biliary cirrhosis; Retrovirus infections
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Oct 2008 Results have been published in 'Alimentary Pharmacology and Therapeutics'.
    • 01 Oct 2008 Primary endpoint 'biochemical response rate' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top